Related Experiment Videos
Herpesvirus vaccines. Development, controversies, and applications
1Food and Drug Administration, Center for Biologics Evaluation and Research, Office of Vaccines Research and Review, Bethesda, Maryland, USA.
Infectious Disease Clinics of North America
|April 13, 1999
Summary
Developing effective herpesvirus vaccines is challenging due to immune evasion. This review discusses varicella vaccine data and explores strategies for herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV) vaccines.
Area of Science:
- Virology
- Immunology
- Vaccinology
Background:
- Herpesviruses pose significant hurdles for vaccine development.
- Their capacity to evade immune clearance complicates the creation of effective vaccines.
Purpose of the Study:
- To review existing data and recommendations for the live-attenuated varicella vaccine.
- To explore novel approaches for developing vaccines against herpes simplex virus (HSV), cytomegalovirus (CMV), and Epstein-Barr virus (EBV).
Main Methods:
- Literature review of varicella vaccine data.
- Analysis of current research and strategies for HSV, CMV, and EBV vaccine development.
Main Results:
- Discussion of the current status and recommendations for the varicella vaccine.
- Identification of challenges and potential pathways for developing vaccines against other herpesviruses.
Conclusions:
- Live-attenuated varicella vaccine data and recommendations are presented.
- Further research into novel vaccine strategies is crucial for preventing illnesses associated with HSV, CMV, and EBV.